Interestingly, ERβ has been correlated with improved survival in non-small cell lung adenocarcinoma, particularly in men [35], although findings from other studies have been mixed [36, 37] and a recent pooled analyses found no association between ERβ expression and survival in NSCLC patients [38]. Here, ESR2 is linked to non-small cell lung carcinoma.